Andrew Hogan

Dr. Andrew Hogan is a Professor at Maynooth University’s Faculty of Science & Engineering, within the Biology department under the Human Health Institute. He leads the Obesity Immunology Research Group, focusing on obesity’s impact on immune systems and co-morbid diseases like Type 2 Diabetes and cancer. His work involves clinical partnerships with institutions such as St. Vincent’s University Hospital and CHI Crumlin. Hogan’s research has produced over 60 peer-reviewed publications in high-impact journals like Nature Immunology and Science Signaling.

Education: Hogan completed undergraduate and postgraduate studies at Maynooth University, followed by a Newman Fellowship in Obesity at University College Dublin (UCD) and a postdoctoral fellowship at Harvard Medical School. His research spans innate immunity, metabolic disorders, and GLP-1 therapy effects.

Research Interests: His group investigates obesity-driven immune dysregulation, MAIT/NK cell dysfunction, and therapeutic interventions targeting inflammation and metabolic pathways. Recent studies include GLP-1’s role in restoring NK cell function and MAIT cell metabolism in cancer.

Grants & Collaborations: Funded by grants from the National Children’s Research Centre, Health Research Board, and Enterprise Ireland. Notable projects include investigating MAIT cells in hidradenitis suppurativa and obesity’s impact on SARS-CoV-2 immunity. The lab collaborates with clinical partners to translate findings into clinical applications.

Lab Team: The group includes 3 postdoctoral scientists, 3 PhD students, and 2 MD students. Collaborators include Prof. Donal O’Shea (UCD) and Prof. Helen Heneghan (St. Vincent’s Hospital).